Improving type 1 diabetes after treatment of immune thrombocytopenia with rituximab: killing two birds with one stone. [electronic resource]
- Diabetes care Sep 2010
- e122 p. digital
Publication Type: Letter
1935-5548
10.2337/dc10-0959 doi
Antibodies, Monoclonal, Murine-Derived--therapeutic use Clinical Trials as Topic Diabetes Mellitus, Type 1--drug therapy Female Humans Immunologic Factors--therapeutic use Rituximab Thrombocytopenia--drug therapy Young Adult